Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
9,132,339
-
Share change
-
-731,287
-
Total reported value
-
$10,225,725
-
Put/Call ratio
-
62%
-
Price per share
-
$1.12
-
Number of holders
-
52
-
Value change
-
-$823,608
-
Number of buys
-
22
-
Number of sells
-
20
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2022
As of 31 Dec 2022 Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,132,339 shares of stock of the company.
Largest 10 holders included Carmignac Gestion, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, FIRST MANHATTAN CO, JOHNSON & JOHNSON, and TWO SIGMA ADVISERS, LP.
This table shows 52 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.